Latent class analysis of noninvasive methods and liver biopsy in chronic hepatitis C: an approach without a gold standard

Fernandes, Flavia F.; Perazzo, Hugo; Andrade, Luiz E.; Dellavance, Alessandra; Terra, Carlos; Pereira, Gustavo; Pereira, João L.; Campos, Frederico; Ferraz, Maria L.; Perez, Renata M..
Artículo en Inglés | ARCA | ID: arc-25783

Documentos relacionados

  1. Le traitement de l'hépatite C réduit la cirrhose et la mortalité chez les personnes qui s'injectent des substances.
  2. Possible relationship between IL28B rs12979860 and TLR2 -196 to -174 del/ins polymorphisms and the liver fibrosis stage in hepatitis C patients.
  3. Hepatitis C treatment threshold in patients with decompensated liver disease.
  4. Unraveling IL-17 and IL-22 role in occult hepatitis C versus chronic hepatitis C virus infection.
  5. Reflex testing. A key tool for the elimination of hepatitis C.
  6. Reactivation of human cytomegalovirus inhibits expression of liver fibrosis related cytokines in patients chronically infected with hepatitis C virus genotype 4a.
  7. Correlation of Antithrombin Functional Status and Levels with Liver Fibrosis in Patients with Hepatitis C.
  8. Admixture Mapping in African Americans Identifies New Risk Loci for HCV-Related Cirrhosis.
  9. MAFLD burden on the Spanish National Health System. A call to action.
  10. Test characteristics for combining non-invasive liver fibrosis staging modalities in individuals with Hepatitis C virus.